Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEM.
Interleukin-10 but not transforming growth factor-β1 gene expression is up-regulated by vitamin D treatment in multiple sclerosis patients.
Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction.
Autoantibodies and pain.
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis.
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.
Episode 25 with actor and science advocate Alan Alda discussing communicating science
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study.
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis.
Potassium channel KIR4.1 as an immune target in multiple sclerosis.
Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis.
Recent insights into the mechanism of action of glatiramer acetate.
Rebif approval application
Multiple sclerosis prevalence in the United States commercially insured population.
Optical Coherence Tomography in Multiple Sclerosis.
Specific inhibition of secreted NRG1 types I-II by heparin enhances Schwann Cell myelination.
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
International Joint Israel-Greek-Italian Neuroimmunological meeting
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
Differential transcriptional response profiles in human myeloid cell populations.
Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients' quality of life.
Microglia across the lifespan: from origin to function in brain development, plasticity and cognition.
WT1 and interferon-β-vitamin D association in MS: a longitudinal study.
A silver lining of neuroinflammation: Beneficial effects on myelination.

Pages